Pirtobrutinib Tablets (Jaypirca) – 100?mg × 14 Tablets × 4 Blisters Price comparison
$2.00
Pirtobrutinib Tablets (brand name: Jaypirca) is the world’s first non-covalent BTK inhibitor, provided here as 100?mg oral film?coated tablets. Manufactured by Lilly del Caribe, Inc. and approved for import in China (NMPA No. HJ20240116; code 86978403001613). Supplied with clear indication for research/investigational use only, not for human therapeutic use.
描述
Pirtobrutinib Tablets Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Pirtobrutinib Tablets (Jaypirca) |
| Formulation | Film-coated tablet, 100?mg |
| Pack Size | 14 tablets × 4 blisters = 56 tablets per box |
| Approval No. | China NMPA HJ20240116 |
| Product Code | 86978403001613 |
| Manufacturer | Lilly del Caribe, Inc. |
| Intended Use | Research/Investigational use only; not for human use |
Pirtobrutinib Tablets Overview & Mechanism
Pirtobrutinib is a highly selective, non-covalent Bruton’s Tyrosine Kinase (BTK) inhibitor. It is effective against BTK-resistant mutations and approved for relapsed/refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in the US, EU, and China medlineplus.gov+15biopharmaboardroom.com+15trial.medpath.com+15
Pirtobrutinib Tablets Key Clinical Notes
-
FDA (Jan 2023): Accelerated approval for R/R MCL after ?2 prior treatments fr.wikipedia.org+8fda.gov+8onclive.com+8.
-
EU (Nov 2023): EMA authorized Jaypirca for R/R MCL; CHMP recommended for R/R CLL
-
China (Oct 2024): NMPA approval as Jaypirca 50?mg/100?mg tablets under HJ20240116
Research Applications
Suitable for preclinical and translational oncology research, including:
-
BTK pathway and resistance studies
-
In vitro cytotoxicity assays and animal models
-
Combinatorial investigations with immunotherapies or targeted agents
Handling & Storage
-
Storage: Room temperature 20–25?°C (per USP), excursions 15–30?°C
-
Handling: Standard lab PPE required; avoid ingestion, inhalation, skin/eye contact. Use biosafety protocol.
? References
-
China NMPA approval under HJ20240116 pi.lilly.com+3trial.medpath.com+3biospectrumasia.com+3
-
FDA accelerated approval Jan 2023 (MCL) en.wikipedia.org+6jhoponline.com+6biopharmaboardroom.com+6
-
EMA authorization & CHMP opinion ema.europa.eu+1onclive.com+1
-
Clinical and prescribing info: dosage, interactions, warnings fr.wikipedia.org
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
Pirtobrutinib Tablets (Jaypirca) – 100?mg × 14 Tablets × 4 Blisters Price comparison 有 1 个评价
相关产品
-
Limertinib Tablets 80?mg ×?20 – by Osscon Pharma | Research Use Only (3rd?Gen EGFR?TKI)
Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR?TKI) at 80?mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it targets EGFR T790M?mutated non?small cell lung cancer, including patients with brain metastases.
?? For research use only – Not for human consumption or therapeutic use. $1.00 -
Reduced Glutathione Injection 0.6?g × 10 Vials – Ruiyang | Price comparison
Ruiyang Reduced Glutathione Injection (0.6?g per vial × 10) by Ruiyang Pharmaceutical Co., Ltd. Ideal for antioxidant, detoxification, and hepatic-protection research in metabolic and oxidative stress studies.
?? For laboratory research use only – Not for human consumption or therapeutic use. $2.00 -
Cetuximab NO1 Injection 100?mg/50?mL (Datalai) by Kelun Botai | EGFR?Targeted Biologic | Price comparison
Cetuximab NO1 Injection, 100?mg in 50?mL vial, is a biosimilar developed by Sichuan Kelun Botai Biopharma, branded as Datalai®. Approved in China (NMPA S20250006), this EGFR-targeting monoclonal antibody is ideal for laboratory or analytical research in oncology.
?? For laboratory research use only – Not for human consumption or therapeutic use. $1.00 -
Palbociclib Capsules (Xipeilai) – 125?mg, 21 Capsules Price comparison
Palbociclib Capsules (Research Grade) in 125?mg strength, 21-count bottle. Supplied by Shanghai Chuannuo Pharmaceutical Co., Ltd. For investigational or research applications only—not for human consumption or therapeutic use.
$2.00
manuelarana –
I’ve been looking for it for a long time, thank you